FT
Thermo Fisher’s €10.7bn takeover of Qiagen collapses after investor revolt
Failure marks a rare example of a deal faltering because Covid-19 improved target’s performance
Failure marks a rare example of a deal faltering because Covid-19 improved target’s performance